Table 1.
Patient data
| Pathologist diagnosis | Cancer type | Tumour type | FIGO stage | Silverberg classification | WHO classification | CA125 levels (from pathology reports) | Peripheral blood CA125 at diagnosis | Ascites present at diagnosis | Genetic information | Survived from diagnosed till death | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Benign sclerosis tumour | Benign | Benign | -- | -- | -- | Increased | 69 | no | Nil Ca | -- |
| 2 | Normal ovaries and Fallopian tubes | Normal | Normal | -- | -- | -- | N/A | N/A | no | BRCA1+ | -- |
| 3 | Benign serous cystadenoma | Normal- Peutz-Jegher's syndrome | Benign | -- | -- | -- | N/A | N/A | no | Peutz-Jegher's syndrome | -- |
| 4 | Fibroma-mitotically active | Benign | Benign | -- | -- | -- | N/A | >7 | no | Nil Ca | -- |
| 5 | Serous cystadenofibroma | Large multi cystic ovarian mass (benign) | Benign | -- | -- | -- | N/A | N/A | no | Nil Ca | -- |
| 6 | Serous cystadenofibroma | Cyst benign | Benign | -- | -- | -- | N/A | 6 | no | Diagnosed with Breast Ca | -- |
| 7 | Serous cystadenofibroma | Large ovarian cyst (benign) | Benign | -- | -- | -- | N/A | >27 | no | No info. available | -- |
| 8 | Simple serous cyst | Benign | Benign | -- | -- | -- | N/A | N/A | no | HNPCC carrier (colorectal Ca) | -- |
| 1 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIc | G3 | II | 300 | 223 | no | No (mother kidney Ca, Breast Ca) | -- |
| 2 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIc | G3 | II | N/A | 24 | yes | No (sister died melanoma) | -- |
| 3 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IIc | G3 | II | 109 | 107 | no | Nil Ca | 7 years 7 months |
| 4 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIc | G3 | II | N/A | N/A | unknown | Nil Ca | -- |
| 5 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IIb | G2 | II | 1404 | 1404 | no | Nil Ca | -- |
| 6 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IIIa | G3 | II | N/A | 104 | yes | BRCA2+ve | 5 years 1 months |
| 7 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIIc | G2 | II | N/A | N/A | yes | Nil Ca | -- |
| 8 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIIc | G2 | II | 1200 | N/A | N/A | Nil Ca | -- |
| 9 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIIc | G2 | II | N/A | 428 | yes | N/A | 3 years 7months |
| 10 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIIc | G3 | II | N/A | 4831 | yes | Nil Ca | 4 years 1months |
| 11 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IIIc | G3 | II | 1230 | 1113 | yes | BRCA2 +ve | -- |
| 12 | Serous carcinoma | Carcinoma NOS | Malignant | IIIc | G3 | II | N/A | 3058 | yes | BRCA1 +ve | 2 years 7months |
| 13 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IIIc | G3 | II | Increased | 3025 | yes | Nil Ca | 2 years 5months |
| 14 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IIIc | G3 | II | Increased | 957 | yes | Nil Ca | -- |
| 15 | Serous carcinoma | Serous surface papillary carcinoma | Malignant | IIIc | G3 | II | 374 | 397 | yes | BRCA2 +ve | 4 years 7months |
| 16 | Serous carcinoma | Papillary serous cystadenocarcinoma | Malignant | IV | G2 | II | N/A | 3187 | yes | sister with Ca | 6 years 10months |
| 17 | Serous carcinoma | Serous cystadenocarcinoma NOS | Malignant | IV | G2 | II | Raised | 333 | N/A | BRCA2 carrier | 3years 11months |
II Type II classification/ High grade tumour, Nil Ca negative for BRCA mutations and no family history of Cancer, Ca Cancer, N/A no data available